NEXGEL, Inc. (NASDAQ:NXGL - Get Free Report) Director Scott Robert Henry sold 3,000 shares of the business's stock in a transaction dated Tuesday, January 7th. The stock was sold at an average price of $3.37, for a total transaction of $10,110.00. Following the transaction, the director now owns 141,553 shares in the company, valued at $477,033.61. The trade was a 2.08 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link.
Scott Robert Henry also recently made the following trade(s):
- On Friday, December 20th, Scott Robert Henry sold 3,000 shares of NEXGEL stock. The stock was sold at an average price of $4.64, for a total transaction of $13,920.00.
NEXGEL Price Performance
NASDAQ:NXGL opened at $3.43 on Thursday. NEXGEL, Inc. has a one year low of $1.84 and a one year high of $5.10. The stock has a market cap of $23.29 million, a PE ratio of -5.91 and a beta of 0.61. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.93 and a current ratio of 1.51. The stock has a 50 day moving average price of $3.71 and a 200 day moving average price of $3.00.
Institutional Trading of NEXGEL
A hedge fund recently raised its stake in NEXGEL stock. Northeast Financial Group Inc. lifted its position in NEXGEL, Inc. (NASDAQ:NXGL - Free Report) by 168.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 31,848 shares of the company's stock after purchasing an additional 20,000 shares during the quarter. Northeast Financial Group Inc. owned about 0.50% of NEXGEL worth $82,000 at the end of the most recent reporting period. 2.21% of the stock is currently owned by institutional investors.
About NEXGEL
(
Get Free Report)
This Crypto Is Set to Explode in January
From Crypto 101 Media | Ad
It's a groundbreaking opportunity that could be poised for extraordinary gains.
The catalyst behind this surge is a massive new blockchain development…
YES, I WANT THE #1 CRYPTO NOW
NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
